CACNA1C and neurodevelopmental disorder: The association of rare deleterious mutations in genes encoding VGCC subunits, including CACNA1C, with schizophrenia and other neurodevelopmental disorders further supports the view that decreased CACNA1C expression can contribute to disease risk [11, 12].